Outlook Therapeutics, Inc.

OTLK · NASDAQ
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Assets
Cash & Equivalents$8,083$0$0$0
Short-Term Investments$0$0$0$0
Receivables$1,491$0$0$0
Inventory$3,338$0$0$0
Other Curr. Assets$4,477$0$0$0
Total Curr. Assets$17,389$0$0$0
Property Plant & Equip (Net)$226$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$970$0$0$0
Total NC Assets$1,195$0$0$0
Other Assets$0$0$0$0
Total Assets$18,584$0$0$0
Liabilities
Payables$10,192$0$0$0
Short-Term Debt$59$0$0$0
Tax Payable$302$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$35,261$0$0$0
Total Curr. Liab.$45,815$0$0$0
LT Debt$189$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,768$0$0$0
Total NC Liab.$4,957$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$50,772$0$0$0
Equity
Pref Stock$0$0$32,301$28,528
Common Stock$539$0$0$0
Retained Earnings-$605,710-$1-$0-$0
AOCI$0$0-$32,301$0
Other Equity$572,983$0$0-$28,527
Total Equity-$32,188-$0-$0$0
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$18,584$0$0$0
Net Debt-$7,835$0$0-$0